Condition: Crohn's Disease · Sponsor: University College, London
This study aims to investigate if MR Enterography (MRE) improves the ability to predict which Crohn's disease patients will relapse quickly (disease comes back) after stopping biologic medication. MRE is a safe MRI scan of the bowel, widely used in Crohn's disease patients.
This description comes directly from the study's public registry record.
Maira Hameed · 020 7679 9274 · maira.hameed@ucl.ac.uk
Elizabeth Isaac · 02034474415 · e.isaac@nhs.net
Always discuss trial participation with your own doctor first.
| University College London Hospital | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06124287